Anti-KLC1 monoclonal antibody

Pre-made anti-KLC1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to KLC1/KLC1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2564-Ab-1/ GM-Tg-hg-IP2564-Ab-2Anti-Human KLC1 monoclonal antibodyHuman
GM-Tg-rg-IP2564-Ab-1/ GM-Tg-rg-IP2564-Ab-2Anti-Rat KLC1 monoclonal antibodyRat
GM-Tg-mg-IP2564-Ab-1/ GM-Tg-mg-IP2564-Ab-2Anti-Mouse KLC1 monoclonal antibodyMouse
GM-Tg-cynog-IP2564-Ab-1/ GM-Tg-cynog-IP2564-Ab-2Anti-Cynomolgus/ Rhesus macaque KLC1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2564-Ab-1/ GM-Tg-felg-IP2564-Ab-2Anti-Feline KLC1 monoclonal antibodyFeline
GM-Tg-cang-IP2564-Ab-1/ GM-Tg-cang-IP2564-Ab-2Anti-Canine KLC1 monoclonal antibodyCanine
GM-Tg-bovg-IP2564-Ab-1/ GM-Tg-bovg-IP2564-Ab-2Anti-Bovine KLC1 monoclonal antibodyBovine
GM-Tg-equg-IP2564-Ab-1/ GM-Tg-equg-IP2564-Ab-2Anti-Equine KLC1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2564-Ab-1/ GM-Tg-hg-IP2564-Ab-2; GM-Tg-rg-IP2564-Ab-1/ GM-Tg-rg-IP2564-Ab-2;
GM-Tg-mg-IP2564-Ab-1/ GM-Tg-mg-IP2564-Ab-2; GM-Tg-cynog-IP2564-Ab-1/ GM-Tg-cynog-IP2564-Ab-2;
GM-Tg-felg-IP2564-Ab-1/ GM-Tg-felg-IP2564-Ab-2; GM-Tg-cang-IP2564-Ab-1/ GM-Tg-cang-IP2564-Ab-2;
GM-Tg-bovg-IP2564-Ab-1/ GM-Tg-bovg-IP2564-Ab-2; GM-Tg-equg-IP2564-Ab-1/ GM-Tg-equg-IP2564-Ab-2
Products NameAnti-KLC1 monoclonal antibody
Formatmab
Target NameKLC1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-KLC1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2564-Ag-1Recombinant multi-species KLC1/ KLC/ KNS2 protein


    Target information

    Target IDGM-IP2564
    Target NameKLC1
    Gene ID3831,16593,171041,695677,100855591,101099130,508999,100055290
    Gene Symbol and SynonymsKLC,KLC1,KNS2,KNS2A
    Uniprot AccessionQ07866,P37285
    Uniprot Entry NameKLC1_HUMAN,KLC1_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseProstate Cancer
    Gene EnsemblENSG00000126214
    Target ClassificationN/A

    The target: KLC1, gene name: KLC1, also named as KLC, KNS2, KNS2A. Conventional kinesin is a tetrameric molecule composed of two heavy chains and two light chains, and transports various cargos along microtubules toward their plus ends. The heavy chains provide the motor activity, while the light chains bind to various cargos. This gene encodes a member of the kinesin light chain family. It associates with kinesin heavy chain through an N-terminal domain, and six tetratricopeptide repeat (TPR) motifs are thought to be involved in binding of cargos such as vesicles, mitochondria, and the Golgi complex. Thus, kinesin light chains function as adapter molecules and not motors per se. Although previously named "kinesin 2", this gene is not a member of the kinesin-2 / kinesin heavy chain subfamily of kinesin motor proteins. Extensive alternative splicing produces isoforms with different C-termini that are proposed to bind to different cargos; however, the full-length nature and/or biological validity of most of these variants have not been determined. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.